3rd Edition of International Heart Congress
June 05-07,2025 | Hybrid Event
Pulmonary Stenosis
Pulmonary stenosis is a cardiovascular condition characterized by the narrowing or constriction of the pulmonary valve, the gateway between the right ventricle of the heart and the pulmonary artery. This narrowing impedes the smooth flow of blood from the heart to the lungs, placing increased strain on the right ventricle. Commonly a congenital defect, pulmonary stenosis varies in severity, with symptoms ranging from mild to severe. Individuals with mild cases may remain asymptomatic for years, while severe cases can lead to symptoms such as chest pain, fatigue, and fainting. Timely diagnosis and intervention, often through surgical procedures or balloon valvuloplasty, are crucial for managing pulmonary stenosis and preventing complications. Regular medical monitoring is essential to ensure optimal heart function and overall well-being for individuals affected by this condition.
Shuping Zhong
University of Southern California, United States
Yong Xiao Wang
Albany Medical Center, United States
Yochai Birnbaum
Baylor College of Medicine, United States
Federico Benetti
Benetti Foundation, Argentina
Thomas Bernd Dschietzig
Relaxera GmbH & Co. KG, Germany
Mekhman N Mamedov
National Research Center for Preventive Medicine, Russian Federation
Narendra Kumar
HeartbeatsZ Academy, United KingdomSubmit your abstract Today
Title : Surgical fetal stem cells implantation in heart failure patients long term results at 14 years
Federico Benetti, Benetti Foundation, Argentina
Title : Exploring new biomarkers of cardiomyopathy
Shuping Zhong, University of Southern California, United States
Title : The development of human relaxin-2 for heart failure with preserved ejection fraction, HFpEF
Thomas Bernd Dschietzig, Relaxera GmbH & Co. KG, Germany
Title : Cancer and cardiovascular diseases: Common pathogenesis mechanisms and risk factors
Mekhman N Mamedov, National Research Center for Preventive Medicine, Russian Federation
Title : Pulse field ablation for atrial fibrillation complications: What do we know yet
Narendra Kumar, HeartbeatsZ Academy, United Kingdom
Title : Lipoprotein (a): The hidden cardiovascular risk
Syed Raza, Awali Hospital, Bahrain